Skip to content

PDL BioPharma, Inc.: filings

Every PDL BioPharma, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 43 filings, each linked to its SEC index.

Filing record ends 2021-03-29

The latest filing in this captured record is a 10-K filed 2021-03-29. No later filing is in the SEC companyfacts record captured on 2026-09-22. PDL BioPharma, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-K2021-03-29fiscal FY 2020561490000882104-21-000035
10-Q2020-11-13fiscal Q3 2020461180000882104-20-000181
10-Q2020-08-07fiscal Q2 2020431240000882104-20-000120
10-Q2020-05-11fiscal Q1 202043880000882104-20-000071
10-K2020-03-11fiscal FY 2019561730000882104-20-000032
10-Q2019-11-06fiscal Q3 2019481420000882104-19-000111
10-Q2019-08-07fiscal Q2 2019471350000882104-19-000089
10-Q2019-05-09fiscal Q1 2019481000000882104-19-000054
10-K2019-03-15fiscal FY 2018531690000882104-19-000016
10-Q2018-11-07fiscal Q3 2018451260000882104-18-000117
10-Q2018-08-09fiscal Q2 2018451260000882104-18-000091
10-Q2018-05-09fiscal Q1 201846920000882104-18-000028
10-K2018-03-16fiscal FY 2017531690000882104-18-000012
10-Q2017-11-13fiscal Q3 2017461250000882104-17-000118
10-Q2017-08-03fiscal Q2 2017451240000882104-17-000075
10-Q2017-05-03fiscal Q1 201746930000882104-17-000045
10-K2017-03-01fiscal FY 2016521650000882104-17-000013
10-Q2016-11-03fiscal Q3 2016461240000882104-16-000206
10-Q2016-08-04fiscal Q2 2016361000000882104-16-000184
10-Q2016-05-04fiscal Q1 201634700000882104-16-000132
10-K2016-02-23fiscal FY 2015431430000882104-16-000112
10-Q2015-11-04fiscal Q3 201536980000882104-15-000079
10-Q2015-08-05fiscal Q2 201536980000882104-15-000050
10-Q2015-05-06fiscal Q1 201535720000882104-15-000029
10-K2015-02-23fiscal FY 2014421400000882104-15-000019
10-Q2014-11-10fiscal Q3 201436980000882104-14-000090
10-Q2014-08-18fiscal Q2 2014361060000882104-14-000070
10-Q2014-05-12fiscal Q1 201440820000882104-14-000039
10-K2014-03-03fiscal FY 2013461500000882104-14-000006
10-Q2013-11-06fiscal Q3 201336980000882104-13-000050
10-Q2013-08-08fiscal Q2 201336980000882104-13-000034
10-Q2013-05-09fiscal Q1 201336740000882104-13-000006
10-K2013-03-01fiscal FY 2012421420001445305-13-000433
10-Q2012-11-05fiscal Q3 201236960001437749-12-010986
10-Q2012-08-02fiscal Q2 201236960001437749-12-007605
10-Q2012-05-03fiscal Q1 201236720001437749-12-004447
10-K2012-02-23fiscal FY 2011421050001437749-12-001692
10-Q2011-11-09fiscal Q3 201136980001140361-11-052675
10-Q2011-07-29fiscal Q2 201135960001140361-11-038580
10-Q2011-04-28fiscal Q1 201133680001140361-11-023629
10-K2011-03-01fiscal FY 201039990001193125-11-050293
10-Q2010-11-09fiscal Q3 201035910001193125-10-254119
10-Q2010-07-29fiscal Q2 201035870001193125-10-170516

Inspect the source

Entity
PDL BioPharma, Inc. / CIK 0000882104
Captured
SEC response SHA-256
149d7068d6d8db8fcfa6f67ce042b2369bf34c96af9a5f65637956ccd61de4c3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000882104.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))